Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors

PLoS One. 2019 Mar 28;14(3):e0214616. doi: 10.1371/journal.pone.0214616. eCollection 2019.

Abstract

Background: Persistent left ventricular (LV) systolic dysfunction in patients with acute lymphocytic myocarditis (LM) is widely unexplored.

Objectives: To assess the frequency and predictors of persistent LV dysfunction in patients with LM and reduced LVEF at admission.

Methods and results: We retrospectively evaluated 89 consecutive patients with histologically-proven acute myocarditis enrolled at three Italian referral hospitals. A subgroup of 48 patients with LM, baseline systolic impairment and an available echocardiographic assessment at 12 months (6-18) from discharge constituted the study population. The primary study end-point was persistent LV dysfunction, defined as LVEF <50% at 1-year, and was observed in 27/48 patients (56.3%). Higher LV end-diastolic diameter at admission (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.04-1.43, p = 0.002), non-fulminant presentation (OR 8.46, 95% CI 1.28-55.75, p = 0.013) and presence of a poor lymphocytic infiltrate (OR 12.40, 95% CI 1.23-124.97, p = 0.010) emerged as independent predictors of persistent LV dysfunction at multivariate analysis (area under the curve 0.91, 95% CI 0.82-0.99). Pre-discharge LVEF was lower in patients with persistent LV dysfunction compared to the others (32%±8 vs. 53%±8, p <0.001), and this single variable showed the best accuracy in predicting the study end-point (area under the curve 0.95, 95% CI 0.89-1.00).

Conclusions: More than half of patients presenting with acute LM and LVEF <50% who survive the acute phase show persistent LV dysfunction after 1-year from hospital discharge. Features of subacute inflammatory process and of established myocardial damage at initial hospitalization emerged as predictors of this end-point.

MeSH terms

  • Acute Disease
  • Adult
  • Female
  • Humans
  • Lymphocytes / pathology*
  • Male
  • Myocarditis / complications*
  • Prognosis
  • Retrospective Studies
  • Stroke Volume
  • Systole
  • Ventricular Dysfunction, Left / complications*
  • Ventricular Dysfunction, Left / diagnosis*
  • Ventricular Dysfunction, Left / physiopathology

Grants and funding

The authors received no specific funding for this work.